SEC Form 4 · accession 0001707685-26-000010
PTC THERAPEUTICS, INC. · PTCT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Christine Marie Utter
Officer — SVP, CHIEF ACCOUNTING OFFICER
Period of report
Jun 17, 2026
Accepted (ET)
Jun 22, 2026 · 5:20 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001070081
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 17, 2026 | M | 19,686 | $25.69 | A | 89,885 | D | |
| Common Stock | Jun 17, 2026 | S | 19,686 | $75.56 | D | 70,199 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $25.69 | Jun 17, 2026 | M | 19,686 | D | — | Feb 14, 2034 | Common Stock | 19,686 | 15,314 | D |
Explanation of responses
- F1This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on March 17, 2026.
- F2This option was granted on February 15, 2024, and vests over four years, with 25% of the shares underlying the option vesting on February 15, 2025, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on May 15, 2025.